Structure and function of vascular endothelial growth factor receptor-1 and -2

Current Topics in Microbiology and Immunology

Volumn 237, Issue , 1999, Pages 60-83

  Shibuya, M ^a   Ito, N ^a   Claesson Welsh, L ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; HEPARIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; PROTEINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; AUTOPHOSPHORYLATION; BINDING AFFINITY; BIOSYNTHESIS; BLOOD VESSEL; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CHROMOSOMAL LOCALIZATION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE; GENE STRUCTURE; HUMAN; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

CAPILLARY PERMEABILITY; CELL MOVEMENT; CHROMOSOME MAPPING; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HEPARIN; HUMANS; LYMPHOKINES; MACROPHAGES; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS (GENETICS); PROTEIN-TYROSINE KINASES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032890052     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-59953-8_4     Document Type: Article

References (92)

1. Aliello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461
2. Barleon B, Sozzani S, Zhou D, Weich HA, Martovani A, Marme D (1996) Migration of human monocytes in response to Vascular Endothelilal Growth Factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336-3343
3. Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G, Marme D, Martiny-Baron G (1997) Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. J Biol Chem 272:10382-10388
4. Blechman JM, Lev S, Barg J, Eisenstein M, Vaks B, Vogel Z, Givol D, Yarden Y (1995) The fourth immunoglobulin domain of the Stern Cell Factor receptor couples ligand binding to signal transduction. Cell 80:103-113
5. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Varker PJ, Wright KA, Twentyman PR, Smith SK (1995) Expression of vascular endothelial growth factor and its receptors lit and KDR in ovarian carcinoma. J Natl Cancer Inst 87:506-516
6. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger DR (1993) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143:1255-1262
7. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhard! C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439
8. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D (1990) Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte misration. J Exp Med 172:1535-1545
9. Clauss M, Weicht H, Breier G, Knies U, Rockl W, Waltenberger J, Risau W (1996) The vascular endothelial growth factor receptor Fit-1 mediates biological activities. J Biol Chem 271:17629-17634
10. Cohen T, Gitay-Goren H, Sharon R, Shibuya M, Halaban R, Levi BZ, Neufeld G (1995) VEGFI21, a VEGF isoform lacking heparin binding ability, requires cell surface heparin-sulfates for eflecient binding to the VEGF receptors of human melanoma cells. J Biol Chem 270:11322-11326
11. Cunningham SA, Waxham MN, Arrate PM, Brock TA (1995) Interaction of the Flt-I tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 270:20254-20257
12. Davis-Smyth T, Chen H, Park J, Presta LG, Ferrara N (1996) The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 15:4919-4927
13. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Clafley KP (1997) Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/ VEGF) and its receptors in human skin. J Invest Dermatol 108:263-268
14. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991
15. Dougher AM, Wasserstrom H, Torley L, Shridaran L, Westdock P, Hileman RE, Fromm JR, Anderberg R, Lyman S, Linhardt RJ, Kaplan J, Terman BI (1997) Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor. Growth Factors 4:257-268
16. Dougher-Vermazen M, Hulmes JD, Bohlen P, Terman BI (1994) Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. Biochem Biophys Res Commun 205:728-738
17. Ergun S, Kilic N, Fiedler W, Mukhopadhyay AK (1997) Vascular endothelial growth factor and its receptors in normal human testicular tissue. Mol Cell Endocrinol 131:9-20
18. Ferrara N, Career-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442
19. Finnerty H, Kelleher K, Morris GE, Bean K, Merberg DM, Kriz R, Morris JC, Sookdeo H, Turner KJ, Wood CR (1993) Molecular cloning of murine FLT and FLT4. Oncogene 8:2293-2298
20. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
21. Fong GH, Rossant J, Gertsentein M, Breitman ML (1995) Role of the FIt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70
22. Gerber HP, Condorelli F, Park J, Ferrara N (I997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Diol Chem 272:23659-23667
23. Guo D, Jia Q, Song HY, Warren RS, Donner DB (1995) Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J Biol Chem 270:6729-6733
24. Hatva E, Böhling T, Jääskeläinen J, Persico MG, Haltia M, Alitalo K (1996) Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 148:763-775
25. Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA, in press
26. Ikeda T, Wakiya K, Shibuya M (1996) Characterization of the promoter region for flt-1 tyrosine kinase gene, a receptor for vascular endothelial growth factor. Growth Factors 13:151-162
27. Ito N, Wernstedt C, Engström U, Claesson-Welsh L (1998) Identification of VEGF receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules. J Biol Chem, in press
28. Iwasaka C, Tanakh K, Abe M, Sato Y (1996) Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the mieration of vascular endothelial cells. J Cell Physiol 169:522-531
29. Jakeman L, Winer J, Bennett GL, Alter CA, Ferrara N (1992) Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J Clin Invest 89:244-253
30. Jakeman LB, Armanini M, Phillips HS, Ferrara N (1993) Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133:848-859
31. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898-3911
32. Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI, Alitalo K (1993) The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 178:2077-2088
33. Kanda S, Landgren E, Ljungstrom M, Claesson-Welsh L (1996) Fibroblasl growth factor receptor 1-induced differentiation of endothelial cell line established from tsA58 large T transgenic mice. Cell Growth DifTer 7:383-395
34. Kendall RL, Thomas KA (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90:10705-10709
35. Kendall RL, Wang G, DiSalvo J, Thomas KA (1994) Specificity of vascular endothelial cell growth factor receptor ligand binding domains. Biochem Biophys Res Commun 201:326-330
36. Kendall RL, Wang G, Thomas KA (1996) Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226:324-328
37. Kondo K, Hiratsuka S, Subbalakshmi E, Matsushime H, Shibuya M (1998) Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between 7-Ig and the 5-lg tyrosine kinase receptors. Gene (in press)
38. Kremer C, Breier G, Risau W, Plate KH (1997) Up-regulation of fik-l/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res 57:3852-3859
39. Kroll J, Waltenberger J (1997) The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 272:32521-32527
40. Landgren E, Schiller P, Cao Y, Claesson-Welsh L (1998) Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Fit 1. Oncogene 16:359-367
41. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 88:9267-9271
42. Maglione D, Guerriero V, Viglietto G, Ferraro MG, Aprelikova O, Alitalo K, Vecchio SD, Lei KJ, Chou JY, Persico MG (1993) Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PIGF), are transcribed from a single gene of chromosome 14. Oncogene 8:925-931
43. Maru Y, Yamaguchi S, Shibuya M (1998) Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials. Oncogene (in press)
44. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
45. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR (1991a) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Nail Acad Sci USA 88:9026-9030
46. Matthews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR (1991b) A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143-1152
47. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NPH, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest fik-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846
48. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-579
49. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM (1996) Dominantnegative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res 56:1615-1620
50. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83:7297-7301
51. Morishita K, Johnson DE, Williams LT (1995) A novel promoter for vascular endothelial growth factor receptor (flt:I) that confers endothelial-specific gene expression. J Biol Chem 270:27948-27953
52. Nomura M, Yamanashi SI, Harada SI, Hayashi Y, Yamashima T, Yamashita J, Yamamoto H (1995) Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxiainduced proliferation of endothelial cells and pericytes. J Biol Chem 270:28316-28324
53. Oeberg C, Waltenberger J, Claesson-Welsh L, Welsh M (1994) Expression of protein tyrosine kinases in islet cells: possible role of the Flk-1 receptor for b-cell maturation from duct cells. Growth Factors 10:115-126
54. Park JE, Chen HH, Winer J, Houck KA, Ferrara N (1994) Placenta growth factor: pptentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269:25646-25654
55. Patterson C, Perrella MA, Hsieh CM, Yoshizumi M, Lee ME, Haber E (I995) Cloning and functional analysis of the promoter for KDR/ilk-1, a receptor for vascular endothelial growth factor. J Biol Chem 270:23111-23118
56. Pawson T (1995) Protein modules and signalling networks. Nature 373:573-580
57. Pelicci G, Lanfrancone L, Grignani F, McGlade J, Cavallo F, Forni G, Nicoletti I, Grignani F, Pawson T, Pelicci PG (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104
58. Pepper MS, Ferrara N, Orci L, Montesano R (I991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906
59. Pepper MS, Ferrara N, Orci L, Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824-831
60. Peters KG, De Vries C, Williams LT (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90:8915-8919
61. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848
62. Ronicke V, Risau W, Breier G (1996) Characterization of the endothelium-specific murine vascular endothelial growth factor receptor-2 (Flk-1) promoter. Circ Res 79:277-285
63. Rosnet O, Mattel MG, Marchetto S, Birnbaum D (1991) Isolalion and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics 9:1-6
64. Rosnet O, Stephenson D, Mallei MG, Marchetto S, Shibuya M, Chapman VM, Birnbaum D (1993) Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 8:173-179
65. Rousseau S, Houle F, Landry J, Huot J (1997) p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.Oncogene 15:2169-2177
66. Sail SN, Dougher-Vermazen M, Shows TB, Terman BI (1995) The kinase insert domain receptor gene (KDR) has been relocated lo chromosome 4qll-ql2. Cytogenet Cell Genet 70:145-146
67. Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Demura H, Yamaguchi S, Shibuya M (1995) Stimulation by TSH and Graves' IgG of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and fit mRNA expression in the rat thyroid in vivo. J Clin Invest 96:1295-1302
68. Satoh H, Yoshida MC, Matsushime H, Shibuya M, Sasaki M (1987) Regional localization of the human c-ros-1 on 6q22 and fit on 13ql2. Jpn J Cancer Res (Gann) 78:772-775
69. Sawano A, Takahashi T, Yamaguchi S, Aonuma T, Shibuya M (1996) Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor (P1GF), which is related to vascular endothelial grow th factor (VEGF). Cell Growth Differ 7:213-221
70. Sawano A, Takahashi T, Yamaguchi S, Shibuya M (1997) The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLC-gamma. Biochem Biophys Res Commun 238:487-491
71. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M (1995) A unique signal trans-duction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135-147
72. Shabby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66
73. Shen H, Clauss M, Ryan J, Schmidt AM, Tijburg P, Borden L, Connolly D, Stern D, Kao J (1993) Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81:2767-2773
74. Shibuya M (1995) Role of VEGF-Flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 67:281-316
75. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A, Matsushime H, Sato M (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene ((It) closely related to the fms family. Oncogene 5:519-524
76. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845
77. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ et al (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778
78. Spritz RA, Strunk KM, Lee ST, Lu-Kuo JM, Ward DC, Le Paslier D, Altherr MR, Dorman TE, Moir DT (1994) A YAC contig spanning a cluster of human type HI receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4ql2. Genomics 22:431-436
79. Takahashi T, Shibuya M (1997) The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLCg pathway and partially induces mitotic signals in NIH3T3 fibroblasts. Oncogene 14:2079-2089
80. Tanaka K, Yamaguchi S, Sawano A, Shibuya M (1997) Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase). Jpn J Cancer Res 88:867-876
81. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6:1677-1683
82. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187:1579-1586
83. Terman B, Khandke L, Dougher-Vermazan M, Maglione D, Lassam NJ, Gospodarowicz D, Persico MG, Bohlen P, Eisinger M (1994) VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11:187-195
84. Ullrich A, Schlessinger J (1990) Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212
85. Wakiya K, Begue A, Stehelin D, Shibuya M (1996) A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (Vascular Endothelial Growth Factor Receptor 1) gene. J Biol Chem 271:30823-30828
86. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH (1994) Different signal transduction properties of KDR and Fill, two receptors for Vascular Endothelial Growth Factor. J Biol Chem 269:26988-26995
87. Wernert N, Raes MB, Lassalle P, Dehouck MP, Gosselin B, Vandenbunder B, Stehelin D (1992) c-etsl proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 140:119-127
88. Wizigmann-Voos S, Breier G, Risau W, Plate KH (1995) Up-regulatipn of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 55:1358-1364
89. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, King GL (1996) Characterization of vascular endothclial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98:2018-2026
90. Yamane A, Seetharam L, Yamaguchi S, Gotoh N, Takahashi T, Neufeld G, Shibuya M (1994) A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Fit tyrosine kinase receptor family (FIt-1 and KDR/Flk-1). Oncogene 9:2683-2690
91. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP (1996) Expression of Vascular Endothelial Growth Factor, its receptor and other angiogenic factors in human breast cancer. Cancer Res 56:2013-2016
92. Ziehe M, Maglione D, Ribatt D, Morbidelli L, Lago CT, Battisti M, Paoletti I, Barra A, Tucci M, Parise G, Vincent! V, Granger HJ, Viglietto G, Persico MG (1997) Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest 76:517-531